Data collection | Measurement instrument | Visit 1 Week 0 | Visit 2 Week 2 | Visit 3 Week 4 | Visit 4 Week 8 | Visit 5 Week 12 |
---|---|---|---|---|---|---|
Baseline characteristics | Questionnaire on patient characteristics | X | ||||
Dry mouth severity | X | X | X | X | X | |
Dry mouth impact | Summated Xerostomia Inventory, shortened Dutch version (sXI-D, adapted) [32] | X | X | X | X | X |
Oral health-related quality of life | Geriatric Oral Health Assessment Index, Dutch version (GOHAI-NL) [33] | X | X | X | X | X |
Health-related quality of life | EuroQol 5 Dimensions 5 Levels (EQ-5D-5L) [34] | X | X | X | X | |
Functional status | Patient-reported functional status (PRFS) [35] | X | X | X | X | X |
Patient-perceived effect | X | X | X | X | ||
Patient-reported medical costs | The Institute for Medial Technology Assessment (iMTA) Medical Consumption questionnaire (iMCQ, adapted) [38] | X | X | X | X | |
Medication changes | Changes in medication since the last visit | X | X | X | X | |
Adherencea | Short questionnaire on adherence | X | X | X | X | |
Side-effectsa | Short questionnaire on side-effects | X | X | X | X |